{"database": "lobbying", "table": "lobbying_activities", "rows": [[3237784, "e86e2c46-950b-485d-b41e-eccb79174d92", "Q3", "NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)", 28264, "NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)", 2024, "third_quarter", "PHA", "Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2024-10-15T10:45:24-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3237784"], "units": {}, "query_ms": 13.911350164562464, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}